Olatoyosi Odenike to Infusions, Intravenous
This is a "connection" page, showing publications Olatoyosi Odenike has written about Infusions, Intravenous.
Connection Strength
0.050
-
Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia. N Engl J Med. 2015 Sep 03; 373(10):920-8.
Score: 0.031
-
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia. Invest New Drugs. 2008 Aug; 26(4):331-8.
Score: 0.019